Nonetheless, our analyses demonstrate that differences in mortality exist between those with and without DM and between those taking and not taking insulin therapy, even after accounting for the presence or absence of such potent predictors of mortality as clinical and subclinical CVD, dementia, and functional status. The gene discussed is INS; the disease is dementia.